Publications by authors named "Eve Rodler"

Claim this Profile
A
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Karen L Smith, Fengmin Zhao, Ingrid A Mayer, Amye J Tevaarwerk, Sofia F Garcia, Eve T Rodler

Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Eve Rodler, Priyanka Sharma, William E Barlow, Julie R Gralow, Shannon L Puhalla

Lancet Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery.
Evan Rosenbaum, Rashmi Chugh, Christopher W Ryan, Mark Agulnik, Mohammed M Milhem, Eve T Rodler

Eur J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.
Lynn Symonds, Isaac Jenkins, Hannah M Linden, Brenda Kurland, Julie R Gralow, Eve Rodler

Clin Breast Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to T. Shimoi et al and Y. Shimanuki et al.
Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga, William F Symmans, Ben H Park, Eve T Rodler

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.
Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga, William F Symmans, Ben H Park, Eve T Rodler

J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.
Kristin Baird, John Glod, Seth M Steinberg, Denise Reinke, Joseph G Pressey, Eve T Rodler

Sarcoma· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib.
Lynn Symonds, Hannah Linden, Vijayakrishna Gadi, Larissa Korde, Eve Rodler

Clin Breast Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma.
Robin L Jones, Daniela Katz, Elizabeth T Loggers, Darin Davidson, Eve T Rodler

Med Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer.
Eve T Rodler, Brenda F Kurland, Melissa Griffin, Julie R Gralow, Peggy Porter

Clin Cancer Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chest wall sarcomas: a single-institution experience over 20 years.
Ashley Burt, Jacob Berriochoa, Anna Korpak, Eve Rodler, Robin L Jones

Am J Clin Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of clinical prognostic factors for adult patients with head and neck sarcomas.
Amy E Chang, Xiaoyu Chai, Seth M Pollack, Elizabeth Loggers, Eve Rodler

Otolaryngol Head Neck Surg· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
Prashoban J Bremjit, Robin L Jones, Xiaoyu Chai, Gabrielle Kane, Eve T Rodler

Ann Surg Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates.
Janelle M Meyer, Kelly S Perlewitz, James B Hayden, Yee-Cheen Doung, Arthur Y Hung, Eve T Rodler

Clin Cancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit of trabectedin in uterine adenosarcoma.
Brett A Schroeder, Eve T Rodler, Elizabeth T Loggers, Seth M Pollack, Robin L Jones

Med Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution of systemic therapy in sarcoma.
Anastasia Constantinidou, Seth Pollack, Elizabeth Loggers, Eve Rodler, Robin L Jones

Expert Rev Anticancer Ther· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(18)F-FDG PET in sarcoma treatment response imaging.
Janet F Eary, Douglas S Hawkins, Eve T Rodler, Ernest U Conrad

Am J Nucl Med Mol Imaging· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic therapy in primary angiosarcoma of the spleen.
Bruna Pellini Ferreira, Eve T Rodler, Elizabeth T Loggers, Seth M Pollack, Robin L Jones

Rare Tumors· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.
Seth M Pollack, Achim A Jungbluth, Benjamin L Hoch, Erik A Farrar, Marie Bleakley, Eve Rodler

Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.
Seth M Pollack, Yonqing Li, Megan J Blaisdell, Erik A Farrar, Jeffrey Chou, Eve Rodler

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients.
Brenda F Kurland, Vijayakrishna K Gadi, Jennifer M Specht, Kimberly H Allison, Robert B Livingston, Eve T Rodler

EJNMMI Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current treatment options in triple negative breast cancer.
Eve Rodler, Larissa Korde, Julie Gralow

Breast Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-based therapies for sarcoma.
Seth M Pollack, Elizabeth T Loggers, Eve T Rodler, Cassian Yee, Robin L Jones

Sarcoma· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Clinical Practice Guidelines Cancer-related fatigue.
Ann M Berger, Amy Pickar Abernethy, Ashley Atkinson, Andrea M Barsevick, William S Breitbart, Eve Rodler

J Natl Compr Canc Netw· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature.
Eve Rodler, Jeanna Welborn, Sandra Hatcher, Katherine Unger, Edward Larkin

Am J Hematol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis